Literature DB >> 19766100

TNFalpha induces HIF-1alpha expression through activation of IKKbeta.

Hsu-Ping Kuo1, Dung-Fang Lee, Weiya Xia, Yongkun Wei, Mien-Chie Hung.   

Abstract

The transcription factor hypoxia-inducible factor 1alpha (HIF-1alpha) is regulated by oxygen availability as well as various inflammatory mediators, including tumor necrosis factor alpha (TNFalpha). Early work suggested that the phosphatidylinositol-3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways are involved in TNFalpha-mediated HIF-1alpha accumulation and activation under normoxic conditions. Here, we provide evidence showing that IkappaB kinase beta (IKKbeta) is required for HIF-1alpha regulation by TNFalpha. We found that TNFalpha enhances HIF-1alpha protein expression in various breast cancer cell lines under either normoxic or hypoxia-mimicking conditions, but has little effect on the HIF-1alpha mRNA level. Increased HIF-1alpha expression was found in IKKbeta stable clones and transient transfectants, and depletion of IKKbeta consistently reduced the amount of HIF-1alpha protein. Treatment of cells with the IKKbeta inhibitor Bay 11-7082 reduced the TNFalpha-induced HIF-1alpha expression, suggesting that IKKbeta is required in this signaling pathway. Decreased expression of vascular endothelial growth factor (VEGF), a direct target of HIF-1alpha, was shown in IKKbeta-knockout mouse embryonic fibroblast cells. We further demonstrated a positive correlation between IKKbeta and VEGF expression in primary human breast cancer specimens. Our findings indicate that TNFalpha-induced HIF-1alpha accumulation is IKKbeta dependent, and may enable further understanding of the HIF-1alpha regulation by inflammatory signals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766100      PMCID: PMC2762003          DOI: 10.1016/j.bbrc.2009.09.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

Review 2.  Regulation of angiogenesis by hypoxia: role of the HIF system.

Authors:  Christopher W Pugh; Peter J Ratcliffe
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

3.  A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.

Authors:  Yan M Li; Binhua P Zhou; Jiong Deng; Yong Pan; Nissim Hay; Mien-Chie Hung
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

4.  Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.

Authors:  Hui-Wen Lo; Weiya Xia; Yongkun Wei; Mohamed Ali-Seyed; Shiu-Feng Huang; Mien-Chie Hung
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

5.  Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1.

Authors:  T Hellwig-Bürgel; K Rutkowski; E Metzen; J Fandrey; W Jelkmann
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

6.  Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

Authors:  Li Ma; Zhenbang Chen; Hediye Erdjument-Bromage; Paul Tempst; Pier Paolo Pandolfi
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

Review 7.  All roads lead to mTOR: integrating inflammation and tumor angiogenesis.

Authors:  Dung-Fang Lee; Mien-Chie Hung
Journal:  Cell Cycle       Date:  2007-09-20       Impact factor: 4.534

8.  Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

Authors:  A P Levy; N S Levy; S Wegner; M A Goldberg
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

9.  IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.

Authors:  Dung-Fang Lee; Hsu-Ping Kuo; Chun-Te Chen; Jung-Mao Hsu; Chao-Kai Chou; Yongkun Wei; Hui-Lung Sun; Long-Yuan Li; Bo Ping; Wei-Chien Huang; Xianghuo He; Jen-Yu Hung; Chien-Chen Lai; Qingqing Ding; Jen-Liang Su; Jer-Yen Yang; Aysegul A Sahin; Gabriel N Hortobagyi; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  12 in total

1.  Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Authors:  Goutam Ghosh; Indira V Subramanian; Neeta Adhikari; Xiaoxiao Zhang; Hemant P Joshi; David Basi; Y S Chandrashekhar; Jennifer L Hall; Sabita Roy; Yan Zeng; Sundaram Ramakrishnan
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.

Authors:  Tatiana Correa Carneiro-Lobo; Luiza Coimbra Scalabrini; Leila da Silva Magalhães; Laura B Cardeal; Felipe Silva Rodrigues; Edmilson Ozorio Dos Santos; Albert S Baldwin; Elena Levantini; Ricardo J Giordano; Daniela Sanchez Bassères
Journal:  Lung Cancer       Date:  2019-02-25       Impact factor: 5.705

3.  Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection.

Authors:  Ekaterina Maidji; Giovanni Nigro; Takako Tabata; Susan McDonagh; Naoki Nozawa; Stephen Shiboski; Stefania Muci; Maurizio M Anceschi; Natali Aziz; Stuart P Adler; Lenore Pereira
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

4.  Nicotinamide riboside, an NAD+ precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages.

Authors:  Hyunju Kang; Young-Ki Park; Ji-Young Lee
Journal:  Lab Invest       Date:  2021-04-12       Impact factor: 5.662

5.  NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.

Authors:  Ki Hyun Kim; Dongyoung Kim; Ju Yeol Park; Hye Jin Jung; Yong-Hee Cho; Hyoung Kyu Kim; Jin Han; Kang-Yell Choi; Ho Jeong Kwon
Journal:  J Mol Med (Berl)       Date:  2014-12-04       Impact factor: 4.599

6.  Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.

Authors:  W Zhai; Y Sun; M Jiang; M Wang; T A Gasiewicz; J Zheng; C Chang
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

Review 7.  Molecular mechanisms underlying chronic inflammation-associated cancers.

Authors:  Yongzhong Wu; Smitha Antony; Jennifer L Meitzler; James H Doroshow
Journal:  Cancer Lett       Date:  2013-08-26       Impact factor: 8.679

Review 8.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2012-05-10

9.  Leishmania Infection Induces Macrophage Vascular Endothelial Growth Factor A Production in an ARNT/HIF-Dependent Manner.

Authors:  Tiffany Weinkopff; Hayden Roys; Anne Bowlin; Phillip Scott
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 10.  The NFκB pathway: a therapeutic target in glioblastoma.

Authors:  Lorena Nogueira; Patricia Ruiz-Ontañon; Alfonso Vazquez-Barquero; Francisco Moris; Jose L Fernandez-Luna
Journal:  Oncotarget       Date:  2011-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.